Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab
Study sponsor: Scholar Rock, Inc.
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2026-11-01Estimated
Enrollment · participants238Actual
Source updated2026-09-01Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.